Environmental Monitoring In Advanced Therapeutic Medicinal Products Facilities

By Mark Hallworth, Life Sciences Senior GMP Scientist, Particle Measuring Systems

Advanced Therapeutic Medicinal Products (ATMPs) are changing the face of medicine, but their manufacturing introduces unique environmental challenges that require a departure from traditional biopharma methods. Because ATMP production often involves patient-specific, small-scale batches and complex manual manipulations, the potential for cross-contamination is heightened, demanding a more rigorous approach to aseptic control.

This application note explores how to adapt standard environmental monitoring technologies to these specific requirements, moving beyond traditional methods to a more integrated, continuous strategy. Readers will learn how to design monitoring programs that incorporate total particle counting, microbial sampling, and centralized data dashboards to ensure batch isolation, effective risk management, and regulatory compliance.